The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

被引:0
作者
P. R. Donald
D. P. Parkin
H. I. Seifart
H. S. Schaaf
P. D. van Helden
C. J. Werely
F. A. Sirgel
A. Venter
J. S. Maritz
机构
[1] Stellenbosch University,Paediatrics and Child Health, Faculty of Health Sciences
[2] Stellenbosch University,Department of Pharmacology, Faculty of Health Sciences
[3] Stellenbosch University,Department of Biology and Human Genetics, and the MRC Centre for Molecular and Cellular Biology, DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences
[4] Biostatistics Unit of the South African Medical Research Council,undefined
来源
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词
Isoniazid; Early bactericidal activity; -acetyltransferase-2; Pharmacokinetics; Pharmacodynamics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:633 / 639
页数:6
相关论文
共 50 条
  • [22] Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population
    Yamada, So
    Tang, Mila
    Richardson, Kathryn
    Halaschek-Wiener, Julius
    Chan, Matthew
    Cook, Victoria J.
    Fitzgerald, J. Mark
    Elwood, R. Kevin
    Brooks-Wilson, Angela
    Marra, Fawziah
    PHARMACOGENOMICS, 2009, 10 (09) : 1433 - 1445
  • [23] A COMPETITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETERMINATION OF N-ACETYLTRANSFERASE (NAT2) PHENOTYPES
    WONG, P
    LEYLANDJONES, B
    WAINER, IW
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (09) : 1079 - 1086
  • [24] N-acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients
    Kita, T
    Tanigawara, Y
    Chikazawa, S
    Hatanaka, H
    Sakaeda, T
    Komada, F
    Iwakawa, S
    Okumura, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (05) : 544 - 549
  • [25] Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients
    Fukino, Katsumi
    Sasaki, Yuka
    Hirai, Shigekazu
    Nakamura, Takayuki
    Hashimoto, Masayo
    Yamagishi, Fumio
    Ueno, Koichi
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2008, 33 (02) : 187 - 195
  • [26] The role of isoniazid dosage and NAT2 gene polymorphism in the treatment of tuberculous meningitis
    Jian, Yi
    Bao, Yuhang
    Yang, Fashuang
    Zhu, Mei
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [27] Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
    Doll, Mark A.
    Salazar-Gonzalez, Raul A.
    Bodduluri, Srineil
    Hein, David W.
    ACTA PHARMACEUTICA SINICA B, 2017, 7 (04) : 517 - 522
  • [28] Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy
    Han, Lyrialle W.
    Ryu, Rachel J.
    Cusumano, Michael
    Easterling, Thomas R.
    Phillips, Brian R.
    Risler, Linda J.
    Shen, Danny D.
    Hebert, Mary F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (12) : 1678 - 1689
  • [29] Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure
    Beranger, Agathe
    Bekker, Adrie
    Solans, Belen P.
    Cotton, Mark F.
    Mirochnick, Mark
    Violari, Avy
    Wang, Jiajia
    Cababasay, Mae
    Wiesner, Lubbe
    Browning, Renee
    Moye, Jack
    Capparelli, Edmund, V
    Savic, Radojka M.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (06) : 1037 - 1045
  • [30] Age-distribution and genotype-phenotype correlation for N-acetyltransferase in Argentine children under isoniazid treatment
    Alberto Keller, Guillermo
    Fabian, Lucas
    Gomez, Matias
    Daniel Gonzalez, Claudio
    Alejandro Diez, Roberto
    Di Girolamo, Guillermo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (04) : 292 - 302